These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8176226)

  • 1. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats.
    Yamamoto N; Lindsay DD; Naraparaju VR; Ireland RA; Popoff SN
    J Immunol; 1994 May; 152(10):5100-7. PubMed ID: 8176226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.
    Yamamoto N; Naraparaju VR
    Cell Immunol; 1996 Jun; 170(2):161-7. PubMed ID: 8660814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vitamin D3-binding protein in activation of mouse macrophages.
    Yamamoto N; Naraparaju VR
    J Immunol; 1996 Aug; 157(4):1744-9. PubMed ID: 8759764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.
    Yamamoto N; Kumashiro R
    J Immunol; 1993 Sep; 151(5):2794-802. PubMed ID: 8360493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.
    Yamamoto N; Naraparaju VR
    Immunology; 1996 Aug; 88(4):604-10. PubMed ID: 8881764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A defect in beta-galactosidase of B lymphocytes in the osteopetrotic (op/op) mouse.
    Yamamoto N; Naraparaju VR
    Immunol Lett; 1996 Apr; 50(1-2):35-40. PubMed ID: 8793557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The toothless osteopetrotic rat has a normal vitamin D-binding protein-macrophage activating factor (DBP-MAF) cascade and chondrodysplasia resistant to treatments with colony stimulating factor-1 (CSF-1) and/or DBP-MAF.
    Odgren PR; Popoff SN; Safadi FF; MacKay CA; Mason-Savas A; Seifert MF; Marks SC
    Bone; 1999 Aug; 25(2):175-81. PubMed ID: 10456382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.
    Yamamoto N; St Claire DA; Homma S; Ngwenya BZ
    Cancer Res; 1988 Nov; 48(21):6044-9. PubMed ID: 3167855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.
    Yamamoto N; Homma S; Haddad JG; Kowalski MA
    Immunology; 1991 Nov; 74(3):420-4. PubMed ID: 1769691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities.
    Mohamad SB; Nagasawa H; Uto Y; Hori H
    Anticancer Res; 2002; 22(6C):4297-300. PubMed ID: 12553073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of defective and normal immunologic functions in lymphocytes and macrophages from osteopetrotic (op) rats.
    Hochman N; Wahl LM; Sandberg AL
    J Immunol; 1982 Jul; 129(1):278-81. PubMed ID: 7086133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.
    Yamamoto N; Homma S; Millman I
    J Immunol; 1991 Jul; 147(1):273-80. PubMed ID: 2051023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of serum proteins in the inflammation-primed activation of macrophages.
    Yamamoto N; Willett NP; Lindsay DD
    Inflammation; 1994 Jun; 18(3):311-22. PubMed ID: 8088927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of vitamin D binding protein-macrophage activating factor and colony-stimulating factor-1 on hematopoietic cells in normal and osteopetrotic rats.
    Benis KA; Schneider GB
    Blood; 1996 Oct; 88(8):2898-905. PubMed ID: 8874186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation process of macrophages after in vitro treatment of mouse lymphocytes with dodecylglycerol.
    Homma S; Yamamoto N
    Clin Exp Immunol; 1990 Feb; 79(2):307-13. PubMed ID: 2178824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations.
    Schneider GB; Benis KA; Flay NW; Ireland RA; Popoff SN
    Bone; 1995 Jun; 16(6):657-62. PubMed ID: 7669443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of colony stimulating factor-1 gene expression in the skeleton of four osteopetrotic mutations in rats and mice.
    Shalhoub V; Jackson ME; Paradise C; Stein GS; Lian JB; Marks SC
    J Cell Physiol; 1996 Feb; 166(2):340-50. PubMed ID: 8591994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization.
    Yamamoto N; Naraparaju VR
    Immunol Cell Biol; 1998 Jun; 76(3):237-44. PubMed ID: 9682967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective macrophage recruitment and clearance of apoptotic cells in the uterus of osteopetrotic mutant mice lacking macrophage colony-stimulating factor (M-CSF).
    Shimada-Hiratsuka M; Naito M; Kaizu C; Shuying J; Hasegawa G; Shultz LD
    J Submicrosc Cytol Pathol; 2000 Apr; 32(2):297-307. PubMed ID: 11085218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.